Atlas Trials

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Clinical trial NCT06749210 · RECRUITING

Trial details

NCT number
NCT06749210
Sponsor
Ohio State University Comprehensive Cancer Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer of the BreastChemotherapy-induced Neuropathy
Start date
2025-02-19
Primary completion
2029-08-15
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.